moxonidin stada 0,4 mg filmdragerad tablett
2care4 aps - moxonidin - filmdragerad tablett - 0,4 mg - laktosmonohydrat hjälpämne; moxonidin 0,4 mg aktiv substans
oxycodone/naloxone betapharm 20 mg/10 mg depottablett
betapharm arzneimittel gmbh - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 20 mg/10 mg - naloxonhydrokloriddihydrat 11 mg aktiv substans; stearylalkohol hjälpämne; oxikodonhydroklorid 20 mg aktiv substans
moxonidin bijon 0,4 mg filmdragerad tablett
uab bijon medica - moxonidin - filmdragerad tablett - 0,4 mg - laktosmonohydrat hjälpämne; moxonidin 0,4 mg aktiv substans
moxonidin actavis 0,3 mg filmdragerad tablett
actavis group hf. - moxonidin - filmdragerad tablett - 0,3 mg - laktosmonohydrat hjälpämne; moxonidin 0,3 mg aktiv substans - moxonidin
oxycodone/naloxone betapharm 5 mg/2,5 mg depottablett
betapharm arzneimittel gmbh - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 5 mg/2,5 mg - laktosmonohydrat hjälpämne; stearylalkohol hjälpämne; naloxonhydrokloriddihydrat 2,75 mg aktiv substans; oxikodonhydroklorid 5 mg aktiv substans
oxycodone/naloxone betapharm 10 mg/5 mg depottablett
betapharm arzneimittel gmbh - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 10 mg/5 mg - laktosmonohydrat hjälpämne; naloxonhydrokloriddihydrat 5,5 mg aktiv substans; oxikodonhydroklorid 10 mg aktiv substans; stearylalkohol hjälpämne
oxycodone/naloxone betapharm 40 mg/20 mg depottablett
betapharm arzneimittel gmbh - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 40 mg/20 mg - stearylalkohol hjälpämne; naloxonhydrokloriddihydrat 22 mg aktiv substans; oxikodonhydroklorid 40 mg aktiv substans
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
oxycodone/naloxone stada 80 mg/40 mg depottablett
stada arzneimittel ag - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 80 mg/40 mg - natriumlaurilsulfat hjälpämne; naloxonhydrokloriddihydrat 43,6 mg aktiv substans; oxikodonhydroklorid 80 mg aktiv substans
oxycodone/naloxone stada 60 mg/30 mg depottablett
stada arzneimittel ag - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 60 mg/30 mg - natriumlaurilsulfat hjälpämne; naloxonhydrokloriddihydrat 32,7 mg aktiv substans; oxikodonhydroklorid 60 mg aktiv substans